Top Markets
#1 OriginTrail OriginTrail +30.35%
#2 MarsCoin MarsCoin +15.61%
#3 Pons Pons +11.70%
#4 Waves Waves +10.60%
#5 Cysic Cysic +9.72%
#6 Siren Siren +9.04%
#7 TROLL TROLL +7.27%
#8 PulseChain PulseChain +5.89%
#9 Falcon Finance Falcon Finance +5.71%
#10 Euler Euler +5.47%
Coin of the day
OriginTrail OriginTrail
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd.

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762
Kedudukan dalam Saham #22434
Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co.,... Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.
Harga Saham
$1.15
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$88.79M
Perubahan (1 hari)
2.54%
Perubahan (1 tahun)
27.30%
Negara
TW
Perdagangan Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Kategori

Healthcare
Pendapatan untuk Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Chunghwa Chemical Synthesis & Biotech Co., Ltd., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Chunghwa Chemical Synthesis & Biotech Co., Ltd. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT